Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Short term Debt (2024 - 2026)

Updated

Adaptin Bio's Short term Debt was $162,208 in Q2 2026, down 32.6% from the prior quarter.

Analysis

Adaptin Bio (APTN) Short term Debt (2024 - 2026) Analysis & Trends

At the end of FY2024, Short term Debt at Adaptin Bio came in at $1.25 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 162,208.00
Mar 31, 2026 240,698.00
Dec 31, 2024 1.25 Mn
API Access

Adaptin Bio Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=APTN&period=max&api_key=YOUR_API_KEY